Skip to search formSkip to main contentSkip to account menu

ziprasidone

Known as: 5-(2-(4-(3-benzisothiazolyl)piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one, ziprasidone [Chemical/Ingredient], Ziprasidonum 
A benzothiazolylpiperazine derivative and an atypical antipsychotic agent with an antischizophrenic property. Ziprasidone functions as an antagonist… 
National Institutes of Health

Related topics

Related topics

26 relations
Adrenergic alpha-Antagonists [MoA]Congestive heart failureDrug AllergyGilles de la Tourette syndrome

Broader (6)

Antipsychotic AgentsDopamine AntagonistsPiperazinesSerotonin Antagonists

Narrower (3)

CP 88059Geodonziprasidone hydrochloride, monohydrate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
Competent Psychopharmacology
  • D. Gardner
  • Canadian journal of psychiatry. Revue canadienne…
  • 2014
  • Corpus ID: 24835987
There is little doubt that undergraduate and post-graduate training of physicians, pharmacists, and nurses is insufficient to… 
Highly Cited
2012
Highly Cited
2012
Two 6-Week, Randomized, Double-Blind, Placebo-Controlled Studies of Ziprasidone in Outpatients With Bipolar I Depression: Did Baseline Characteristics Impact Trial Outcome?
Abstract Two randomized, double-blind, placebo-controlled, 6-week studies comparing ziprasidone versus placebo for treatment of… 
Highly Cited
2011
Highly Cited
2011
Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
OBJECTIVE To assess efficacy and safety of adjunctive ziprasidone in subjects with bipolar depression treated with lithium… 
2011
2011
Effect of cyclodextrin derivation and amorphous state of complex on accelerated degradation of ziprasidone.
Inclusion complexes of ziprasidone with several β-cyclodextrins [β-CDs; sulfobutylether-β-cyclodextrins (SBEβCD), hydroxypropyl… 
Review
2011
Review
2011
[Hyperprolactinemia in mentally ill patients].
Hyperprolactinemia is a common, but neglected, adverse effect of conventional antipschycotics and of some of the atypical… 
2010
2010
Epidemiologic study of aripiprazole use and the incidence of suicide events
Because second generation antipsychotics (SGA) might affect the risk of suicide, systematic assessment of suicide risk associated… 
2008
2008
The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC): design and baseline subject characteristics.
BACKGROUND Ziprasidone has been used to treat schizophrenia since 2000. It is unknown whether its modest QTc-prolonging effect… 
2008
2008
Long-Term Improvement in Efficacy and Safety After Switching to Ziprasidone in Stable Outpatients with Schizophrenia
ABSTRACT Introduction: The long-term efficacy and tolerability of treatment with ziprasidone following a switch from prior… 
Highly Cited
2006
Highly Cited
2006
The Three-Substituted Indolinone Cyclin-Dependent Kinase 2 Inhibitor 3-[1-(3H-Imidazol-4-yl)-meth-(Z)-ylidene]-5-methoxy-1,3-dihydro-indol-2-one (SU9516) Kills Human Leukemia Cells via Down…
Mechanisms of lethality of the three-substituted indolinone and putatively selective cyclin-dependent kinase (CDK)2 inhibitor 3… 
2006
2006
Cost-effectiveness analysis of schizophrenia relapse prevention : an economic evaluation of the ZEUS (Ziprasidone-Extended-Use-In-Schizophrenia) study in Spain.
OBJECTIVE The aim of this study was to estimate the cost-effectiveness of schizophrenia relapse prevention in Spain using data… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)